Prospective exosome-focused translational research for afatinib study of non-small cell lung cancer patients expressing EGFR (EXTRA study)

被引：0

作者：

Morikawa, Kei ^{[1
]}

Takata, Saori ^{[2
]}

Tanaka, Hisashi ^{[3
]}

Horiuchi, Kazuya ^{[4
]}

Okuma, Yusuke ^{[5
]}

Soejima, Kenzo ^{[6
]}

Nakagawa, Hideyuki ^{[7
]}

Nakahara, Yoshiro ^{[8
]}

Seki, Yoshitaka ^{[9
]}

Bessyo, Akihiro ^{[10
]}

Takahashi, Nobumasa ^{[11
]}

Hayashi, Kentaro ^{[12
]}

Endo, Takeo ^{[13
]}

Takeyama, Ren ^{[14
]}

Maekura, Toshiya ^{[15
]}

Takigawa, Nagio ^{[16
]}

Horimoto, Katsuhisa ^{[17
]}

Matsutani, Noriyuki ^{[18
]}

Seki, Nobuhiko ^{[19
]}

机构：

[1] St Marianna Univ, Div Resp Dis, Dept Internal Med, Sch Med, Kawasaki, Kanagawa, Japan

[2] Kyorin Univ, Mitaka, Tokyo, Japan

[3] Hirosaki Univ, Hirosaki, Aomori, Japan

[4] Showa Univ, Northern Yokohama Hosp, Tokyo, Japan

[5] Natl Canc Ctr Hosp, Kashiwa, Chiba, Japan

[6] Keio Univ, Minato City, Japan

[7] Hirosaki Hosp, Hirosaki, Aomori, Japan

[8] Kitasato Univ, Minato City, Japan

[9] Jikei Univ, Hosp 3, Tokyo, Japan

[10] Okayama Red Cross Hosp, Okayama, Japan

[11] Saitama Cardiovasc & Resp Ctr, Saitama, Japan

[12] Nihon Univ, Chiyoda City, Japan

[13] Mito Med Ctr, Ibaraki, Japan

[14] Tokyo Womens Med Univ, Tokyo, Japan

[15] Hoshigaoka Med Ctr, Hirakata, Osaka, Japan

[16] Kawasaki Med Sch, Kawasaki, Kanagawa, Japan

[17] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan

[18] Teikyo Univ, Mizonokuti Hosp, Kawasaki, Kanagawa, Japan

[19] Teikyo Univ, Tokyo, Japan

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.244

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MO35-6

引用

页码：S1418 / S1419

页数：2

共 50 条

[41] Afatinib: A Review in Advanced Non-Small Cell Lung Cancer
Gillian M. Keating
Targeted Oncology, 2016, 11 : 825 - 835
[42] The safety of afatinib for the treatment of non-small cell lung cancer
Barron, Feliciano
de la Torre-Vallejo, Martha
Luz Luna-Palencia, Rosa
Cardona, Andres F.
Arrieta, Oscar
EXPERT OPINION ON DRUG SAFETY, 2016, 15 (11) : 1563 - 1572
[43] Real World Study of Afatinib in First-Line or Re-Challenge Setting for Patients with EGFR Mutant Non-Small Cell Lung Cancer
Tanaka, H.
Taima, K.
Itoga, M.
Ishioka, Y.
Baba, K.
Shiratori, T.
Tanaka, Y.
Nakagawa, H.
Morimoto, T.
Hasegawa, Y.
Yasugahira, H.
Okudera, K.
Takanashi, S.
Tasaka, S.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S984 - S984
[44] Real world study of afatinib in first-line or re-challenge setting for patients with EGFR mutant non-small cell lung cancer
Tanaka, Hisashi
Taima, Kageaki
Itoga, Masamichi
Ishioka, Yoshiko
Baba, Keisuke
Shiratori, Toshihiro
Tanaka, Yoshihito
Nakagawa, Hideyuki
Tsuchiya, Junichiro
Hasegawa, Yukihiro
Sakamoto, Hiroaki
Yasugahira, Hideo
Okudera, Koichi
Takanashi, Shingo
Tasaka, Sadatomo
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[45] Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer?
Watanabe, Satomi
Hayashi, Hidetoshi
Nakagawa, Kazuhiko
ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (11)
[46] A Single-Institution Experience of Afatinib in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer
Minemura, Hiroyuki
Yokouchi, Hiroshi
Hirai, Kenichiro
Koizumi, Tatsuhiko
Kanazawa, Kenya
Tanino, Yoshinori
Munakata, Mitsuru
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1230 - S1231
[47] Afatinib as a Potential Therapeutic Option for Non-small Cell Lung Cancer Patients with EGFR G724S
Zhao, H.
Wei, Y.
Liu, S.
Jiang, B.
Xiang, J.
Ye, J.
Lizaso, A.
Han-Zhang, H.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S603 - S603
[48] Clinical analysis of EGFR-positive non-small cell lung cancer patients treated with first-line afatinib: A Nagano Lung Cancer Research Group
Sonehara, Kei
Kobayashi, Takashi
Tateishi, Kazunari
Morozumi, Nobutoshi
Yoshiike, Fumiaki
Hachiya, Tsutomu
Ono, Yasushi
Takasuna, Keiichirou
Agatsuma, Toshihiko
Masubuchi, Takeshi
Matsuo, Akemi
Tanaka, Hozumi
Morikawa, Akio
Hanaoka, Masayuki
Koizumi, Tomonobu
THORACIC CANCER, 2019, 10 (05) : 1078 - 1085
[49] A prospective study of biomarker-guided chemotherapy in patients with non-small cell lung cancer
Zhang, Qiang
Zhu, Xiaoli
Zhang, Li
Sun, Siqing
Huang, Jing
Lin, Yong
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (04) : 839 - 846
[50] A prospective study of biomarker-guided chemotherapy in patients with non-small cell lung cancer
Qiang Zhang
Xiaoli Zhu
Li Zhang
Siqing Sun
Jing Huang
Yong Lin
Cancer Chemotherapy and Pharmacology, 2014, 74 : 839 - 846

← 1 2 3 4 5 →